top of page
Home
Our Science
Our Clinical Trial
The KTX-1001 Program
Expanded Access Policy
About Us
Leadership
Board of Directors
Scientific Advisory Board
Clinical Advisory Board
Investors
News & Events
Press Releases
Contact Us
More
Use tab to navigate through the menu items.
Our Leadership
Terry Connolly, Ph.D.
President, Chief Executive Officer, K36 Board Member
Benjamin Winograd
MD, Ph.D.
Chief Medical Officer
Lan Xu, Ph.D.
VP, Preclinical and Translational Development
Chad Lewis, Ph.D., MBA
Senior Director of Chemistry and Manufacturing
Soo Bang
Senior Vice President, Strategy and Operations
Erin Flynt, Ph.D.
Executive Director, Translational Medicine
Sanjana Umarale Miskin
Director, Clinical Science
Julie Vazquez, RN, MSN, CCRA
Director, Clinical Operations
bottom of page
.png)
.png)
.png)